Role of oestrogen receptors in bladder cancer development (Q38099200)

28 August 2017

title

Role of oestrogen receptors in bladder cancer development (English)

1 reference

28 August 2017

1 reference

1 reference

Iawen Hsu

1 reference

28 August 2017

Spencer Vitkus

series ordinal

1 reference

28 August 2017

Jun Da

series ordinal

1 reference

28 August 2017

Shuyuan Yeh

series ordinal

1 reference

28 August 2017

language of work or name

English

0 references

publication date

16 April 2013

1 reference

28 August 2017

published in

Nature Reviews Urology

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

317-326

1 reference

28 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

The epidemiology of bladder and kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Association between smoking and risk of bladder cancer among men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Risk for cancer of the urinary bladder among hairdressers in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Bladder cancer risks in workers manufacturing chemicals for the rubber industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Radiation-associated urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Chronic inflammation and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Gender differences in stage-adjusted bladder cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Gender- and smoking-related bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Long-Term Effects of Neonatal Steroid Exposure on Mammary Gland Development and Tumorigenesis in Mice2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Potential mechanisms of estrogen quinone carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Parity, early menopause and the incidence of bladder cancer in women: A case–control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Bladder cancer, parity, and age at first birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen exposure and bladder cancer risk in Egyptian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Lower Risk in Parous Women Suggests That Hormonal Factors Are Important in Bladder Cancer Etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Bladder cancer and reproductive factors among women in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

GPR30 contributes to estrogen-induced thymic atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Mechanisms of Estradiol-Induced Insulin Secretion by the G Protein-Coupled Estrogen Receptor GPR30/GPER in Pancreatic β-Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Role of GPR30 in endometrial pathology after tamoxifen for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Bladder cancer: epidemiology, staging and grading, and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Delay to formalin fixation effect on breast biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Inconsistent Immunohistochemical Expression Patterns of Four Different CD133 Antibody Clones in Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Interpretation and quantification of immunostains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Incorporation of microwave tissue processing into a routine pathology laboratory: impact on turnaround times and laboratory work patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Genetic susceptibility to distinct bladder cancer subphenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Combined laser capture microdissection and serial analysis of gene expression from human tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Neoplastic transformation of SV40-immortalized human urinary tract epithelial cells by in vitro exposure to 3-methylcholanthrene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Cdc45p assembles into a complex with Cdc46p/Mcm5p, is required for minichromosome maintenance, and is essential for chromosomal DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Promotion of bladder cancer development and progression by androgen receptor signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Inactivation of p53 and Pten promotes invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptor alpha polymorphisms and the risk of malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Oestrogen receptor negative breast cancers exhibit high cytokine content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Putative relationship between hormonal status and serum pyrrolidone carboxypeptidase activity in pre- and post- menopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Male bladder cancer risk and occupational exposure according to a job-exposure matrix-a case-control study in British Columbia, Canada.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Urinary tract infection and risk of bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Urinary Tract Schistosomiasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

De novo muscle invasive bladder cancer: is there a change in trend?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Hormonal and reproductive factors and the risk of bladder cancer in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Elevated luteinizing hormone in serum, breast cancer tissue, and normal breast tissue from breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptor specificity for the effects of estrogen in ovariectomized mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Differential Roles of Estrogen Receptors α and β in Control of B-Cell Maturation and Selection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Re: Skliriset al. Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue.J Pathol 2002;196: 155-162

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptors in the human female lower uninary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Steroid hormone receptors in the female lower urinary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Digital imaging in pathology: theoretical and practical considerations, and applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.53

Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma

31 March 2020

1 reference

12 December 2020

Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.

1 reference

12 December 2020

Oestrogen receptor beta immunohistochemistry: time to get it right?

1 reference

12 December 2020

Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.

1 reference

12 December 2020

Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch

1 reference

12 December 2020

Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine

1 reference

12 December 2020

Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells

1 reference

12 December 2020

Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia

1 reference

12 December 2020

Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma

1 reference

12 December 2020

Schistosoma induced squamous cell carcinoma of the bladder

1 reference

12 December 2020

Laser capture microdissection in the tissue biorepository

1 reference

12 December 2020

Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds

1 reference

12 December 2020

Estrogen receptor protects p53 from deactivation by human double minute-2

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

12 December 2020

Effects of sex hormones on oncogenesis in rat urinary bladder by N-butyl-N-(4-hydroxybutyl)-nitrosamine

1 reference

12 December 2020

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

1 reference

12 December 2020

Oestrogen receptor concentration and macrophage infiltration in human breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2013.53

1 reference

Dimensions Publication ID

28 August 2017

1027795325

0 references

1 reference